Description

The Division of Endocrinology, Diabetes and Metabolism at NYU Langone Health invites applications for the position of Director of the Metabolic Bone Disease Program. This is a leadership role for a clinician with recognized expertise in bone and mineral metabolism who will oversee and expand a comprehensive, system wide program focused on osteoporosis and related skeletal disorders.

Under the direction of the Division Director, the Director of the Metabolic Bone Disease Program will provide clinical, programmatic, and strategic leadership for bone health services across NYU Langone Health. The successful candidate will play a central role in advancing high quality, evidence-based care, strengthening multidisciplinary collaboration, and building a sustainable and nationally visible metabolic bone program.

Clinical Responsibilities

The position is expected to include clinical duties with a clinical focus on metabolic bone disease and osteoporosis. The Director will oversee and work closely with an advanced practice provider dedicated to bone health and will serve as a key referral resource for endocrinologists and other specialists across the NYU Langone network.

Program Leadership and Strategic Development

The Director will lead the Metabolic Bone Disease Program, including oversight and continued development of NYU Langone's osteoporosis screening initiative. This includes clinical leadership of opportunistic and population-based screening efforts and collaboration with radiology, primary care, and institutional leadership to optimize implementation, reach, and impact.

The Director will be expected to initiate and lead clinical research in metabolic bone disease, including investigator initiated and/or industry sponsored clinical trials. This includes identifying novel therapeutic and implementation focused research opportunities, overseeing study development and regulatory submissions, and integrating clinical trials into routine bone health practice across the NYU Langone network.

The Director will work closely with Endocrinology, Rheumatology, Radiology, Internal Medicine, Orthopedics, Geriatrics, Oncology, and other clinical partners to build coordinated, multidisciplinary pathways for patients with complex skeletal disease, and to leverage these collaborations to support patient recruitment and translational research efforts.

Academic Environment

NYU Langone Health offers a rich academic environment with opportunities for teaching, mentorship, and scholarly activity. The Director will contribute to the educational mission of the Division through teaching of fellows, residents, and medical students, and through participation in divisional conferences and educational initiatives.

Salary Range: $250,000-$250,000

The salary range listed is for full-time employment and does not include incentive compensation or benefits. Actual salary may not fall within the listed salary range; consideration will be made for experience, training, hospital/community need, and other factors.

Qualifications

Applicants must hold an MD or MD PhD, be board certified in Endocrinology, Diabetes and Metabolism, and be eligible for medical licensure in New York State. Candidates should demonstrate established expertise in metabolic bone disease and a strong commitment to clinical excellence, program development, and multidisciplinary collaboration. Competitive candidates will have national visibility in bone metabolism or osteoporosis and or a demonstrated track record of leading multicenter or nationally recognized clinical trials in this area. Academic rank will be commensurate with experience and scholarly accomplishments.

Application Instructions

NYU Langone Health is using Interfolio to conduct this search. Applicants to this position receive a free Dossier account and send all application materials, including confidential letters of recommendation, free of charge.

To apply, please submit a curriculum vitae and cover letter describing your interest, expertise, and professional goals. Letters of recommendation are not required upon initial submission but will be solicited for finalists.